Global DNA Gyrase Subunit B (EC 5.99.1.3) Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The DNA Gyrase Subunit B (EC 5.99.1.3) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DNA Gyrase Subunit B (EC 5.99.1.3) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Bacterial Infections accounting for % of the DNA Gyrase Subunit B (EC 5.99.1.3) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While GYR-12 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of DNA Gyrase Subunit B (EC 5.99.1.3) include Abgentis Limited, AstraZeneca Plc, Daiichi Sankyo Company Ltd, Merck & Co., Inc., and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DNA Gyrase Subunit B (EC 5.99.1.3) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe DNA Gyrase Subunit B (EC 5.99.1.3) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of DNA Gyrase Subunit B (EC 5.99.1.3), with revenue, gross margin and global market share of DNA Gyrase Subunit B (EC 5.99.1.3) from 2019 to 2022.
Chapter 3, the DNA Gyrase Subunit B (EC 5.99.1.3) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and DNA Gyrase Subunit B (EC 5.99.1.3) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe DNA Gyrase Subunit B (EC 5.99.1.3) research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DNA Gyrase Subunit B (EC 5.99.1.3) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Bacterial Infections accounting for % of the DNA Gyrase Subunit B (EC 5.99.1.3) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While GYR-12 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of DNA Gyrase Subunit B (EC 5.99.1.3) include Abgentis Limited, AstraZeneca Plc, Daiichi Sankyo Company Ltd, Merck & Co., Inc., and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DNA Gyrase Subunit B (EC 5.99.1.3) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- GYR-12
- DS-2969
- VXC-100
- VT-12008911
- Others
- Bacterial Infections
- Clostridium Diffclie Infections
- Klebsiella Pneumoniae Infections
- Others
- Abgentis Limited
- AstraZeneca Plc
- Daiichi Sankyo Company Ltd
- Merck & Co., Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe DNA Gyrase Subunit B (EC 5.99.1.3) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of DNA Gyrase Subunit B (EC 5.99.1.3), with revenue, gross margin and global market share of DNA Gyrase Subunit B (EC 5.99.1.3) from 2019 to 2022.
Chapter 3, the DNA Gyrase Subunit B (EC 5.99.1.3) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and DNA Gyrase Subunit B (EC 5.99.1.3) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe DNA Gyrase Subunit B (EC 5.99.1.3) research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of DNA Gyrase Subunit B (EC 5.99.1.3)
1.2 Classification of DNA Gyrase Subunit B (EC 5.99.1.3) by Type
1.2.1 Overview: Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type in 2021
1.2.3 GYR-12
1.2.4 DS-2969
1.2.5 VXC-100
1.2.6 VT-12008911
1.2.7 Others
1.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market by Application
1.3.1 Overview: Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Bacterial Infections
1.3.3 Clostridium Diffclie Infections
1.3.4 Klebsiella Pneumoniae Infections
1.3.5 Others
1.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size & Forecast
1.5 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast by Region
1.5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region, (2017-2022)
1.5.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.4 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.6 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
1.6.2 DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
1.6.3 DNA Gyrase Subunit B (EC 5.99.1.3) Trends Analysis
2 COMPANY PROFILES
2.1 Abgentis Limited
2.1.1 Abgentis Limited Details
2.1.2 Abgentis Limited Major Business
2.1.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.1.4 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abgentis Limited Recent Developments and Future Plans
2.2 AstraZeneca Plc
2.2.1 AstraZeneca Plc Details
2.2.2 AstraZeneca Plc Major Business
2.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.2.4 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AstraZeneca Plc Recent Developments and Future Plans
2.3 Daiichi Sankyo Company Ltd
2.3.1 Daiichi Sankyo Company Ltd Details
2.3.2 Daiichi Sankyo Company Ltd Major Business
2.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.3.4 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Daiichi Sankyo Company Ltd Recent Developments and Future Plans
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.4.4 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck & Co., Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 DNA Gyrase Subunit B (EC 5.99.1.3) Players Market Share in 2021
3.2.2 Top 10 DNA Gyrase Subunit B (EC 5.99.1.3) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 DNA Gyrase Subunit B (EC 5.99.1.3) Players Head Office, Products and Services Provided
3.4 DNA Gyrase Subunit B (EC 5.99.1.3) Mergers & Acquisitions
3.5 DNA Gyrase Subunit B (EC 5.99.1.3) New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Market Share by Type (2017-2022)
4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2017-2022)
5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
6.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
6.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
6.3.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
6.3.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
6.3.3 Canada DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
6.3.4 Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
7.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
7.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
7.3.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
7.3.2 Germany DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.3 France DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.5 Russia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.6 Italy DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
8.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
8.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region
8.3.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2017-2028)
8.3.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.3 Japan DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.4 South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.5 India DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.7 Australia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
9.2 South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
9.3 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
9.3.1 South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
9.3.2 Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
9.3.3 Argentina DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
10.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
10.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
10.3.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
10.3.2 Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
10.3.4 UAE DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of DNA Gyrase Subunit B (EC 5.99.1.3)
1.2 Classification of DNA Gyrase Subunit B (EC 5.99.1.3) by Type
1.2.1 Overview: Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type in 2021
1.2.3 GYR-12
1.2.4 DS-2969
1.2.5 VXC-100
1.2.6 VT-12008911
1.2.7 Others
1.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market by Application
1.3.1 Overview: Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Bacterial Infections
1.3.3 Clostridium Diffclie Infections
1.3.4 Klebsiella Pneumoniae Infections
1.3.5 Others
1.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size & Forecast
1.5 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast by Region
1.5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region, (2017-2022)
1.5.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.4 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.6 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
1.6.2 DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
1.6.3 DNA Gyrase Subunit B (EC 5.99.1.3) Trends Analysis
2 COMPANY PROFILES
2.1 Abgentis Limited
2.1.1 Abgentis Limited Details
2.1.2 Abgentis Limited Major Business
2.1.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.1.4 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abgentis Limited Recent Developments and Future Plans
2.2 AstraZeneca Plc
2.2.1 AstraZeneca Plc Details
2.2.2 AstraZeneca Plc Major Business
2.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.2.4 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AstraZeneca Plc Recent Developments and Future Plans
2.3 Daiichi Sankyo Company Ltd
2.3.1 Daiichi Sankyo Company Ltd Details
2.3.2 Daiichi Sankyo Company Ltd Major Business
2.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.3.4 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Daiichi Sankyo Company Ltd Recent Developments and Future Plans
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
2.4.4 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck & Co., Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 DNA Gyrase Subunit B (EC 5.99.1.3) Players Market Share in 2021
3.2.2 Top 10 DNA Gyrase Subunit B (EC 5.99.1.3) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 DNA Gyrase Subunit B (EC 5.99.1.3) Players Head Office, Products and Services Provided
3.4 DNA Gyrase Subunit B (EC 5.99.1.3) Mergers & Acquisitions
3.5 DNA Gyrase Subunit B (EC 5.99.1.3) New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Market Share by Type (2017-2022)
4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2017-2022)
5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
6.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
6.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
6.3.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
6.3.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
6.3.3 Canada DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
6.3.4 Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
7.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
7.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
7.3.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
7.3.2 Germany DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.3 France DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.5 Russia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
7.3.6 Italy DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
8.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
8.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region
8.3.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2017-2028)
8.3.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.3 Japan DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.4 South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.5 India DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
8.3.7 Australia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
9.2 South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
9.3 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
9.3.1 South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
9.3.2 Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
9.3.3 Argentina DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2028)
10.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2028)
10.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
10.3.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2028)
10.3.2 Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
10.3.4 UAE DNA Gyrase Subunit B (EC 5.99.1.3) Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) by Region (2017-2022)
Table 5. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2023-2028)
Table 6. Abgentis Limited Corporate Information, Head Office, and Major Competitors
Table 7. Abgentis Limited Major Business
Table 8. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 9. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AstraZeneca Plc Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Plc Major Business
Table 12. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 13. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Daiichi Sankyo Company Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Daiichi Sankyo Company Ltd Major Business
Table 16. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 17. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Merck & Co., Inc. Major Business
Table 20. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 21. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 23. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 24. Breakdown of DNA Gyrase Subunit B (EC 5.99.1.3) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. DNA Gyrase Subunit B (EC 5.99.1.3) Players Head Office, Products and Services Provided
Table 26. DNA Gyrase Subunit B (EC 5.99.1.3) Mergers & Acquisitions in the Past Five Years
Table 27. DNA Gyrase Subunit B (EC 5.99.1.3) New Entrants and Expansion Plans
Table 28. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) by Type (2017-2022)
Table 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2017-2022)
Table 30. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Forecast by Type (2023-2028)
Table 31. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022)
Table 32. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Forecast by Application (2023-2028)
Table 33. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 34. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 35. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 36. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 37. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 38. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 39. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 40. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 41. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 42. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 43. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 44. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 45. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 46. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 47. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 48. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 49. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2017-2022) & (USD Million)
Table 50. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2023-2028) & (USD Million)
Table 51. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 52. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 53. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 54. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 55. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 56. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 57. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 58. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 59. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 60. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 61. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 62. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) by Region (2017-2022)
Table 5. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2023-2028)
Table 6. Abgentis Limited Corporate Information, Head Office, and Major Competitors
Table 7. Abgentis Limited Major Business
Table 8. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 9. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AstraZeneca Plc Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Plc Major Business
Table 12. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 13. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Daiichi Sankyo Company Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Daiichi Sankyo Company Ltd Major Business
Table 16. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 17. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Merck & Co., Inc. Major Business
Table 20. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product and Solutions
Table 21. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 23. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 24. Breakdown of DNA Gyrase Subunit B (EC 5.99.1.3) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. DNA Gyrase Subunit B (EC 5.99.1.3) Players Head Office, Products and Services Provided
Table 26. DNA Gyrase Subunit B (EC 5.99.1.3) Mergers & Acquisitions in the Past Five Years
Table 27. DNA Gyrase Subunit B (EC 5.99.1.3) New Entrants and Expansion Plans
Table 28. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) by Type (2017-2022)
Table 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2017-2022)
Table 30. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Forecast by Type (2023-2028)
Table 31. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022)
Table 32. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Forecast by Application (2023-2028)
Table 33. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 34. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 35. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 36. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 37. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 38. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 39. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 40. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 41. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 42. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 43. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 44. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 45. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 46. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 47. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 48. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 49. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2017-2022) & (USD Million)
Table 50. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2023-2028) & (USD Million)
Table 51. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 52. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 53. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 54. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 55. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 56. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
Table 57. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2017-2022) & (USD Million)
Table 58. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2023-2028) & (USD Million)
Table 59. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2017-2022) & (USD Million)
Table 60. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2023-2028) & (USD Million)
Table 61. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2017-2022) & (USD Million)
Table 62. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. DNA Gyrase Subunit B (EC 5.99.1.3) Picture
Figure 2. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type in 2021
Figure 3. GYR-12
Figure 4. DS-2969
Figure 5. VXC-100
Figure 6. VT-12008911
Figure 7. Others
Figure 8. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application in 2021
Figure 9. Bacterial Infections Picture
Figure 10. Clostridium Diffclie Infections Picture
Figure 11. Klebsiella Pneumoniae Infections Picture
Figure 12. Others Picture
Figure 13. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2017-2028)
Figure 16. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region in 2021
Figure 17. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
Figure 23. DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
Figure 24. DNA Gyrase Subunit B (EC 5.99.1.3) Market Trends
Figure 25. Abgentis Limited Recent Developments and Future Plans
Figure 26. AstraZeneca Plc Recent Developments and Future Plans
Figure 27. Daiichi Sankyo Company Ltd Recent Developments and Future Plans
Figure 28. Merck & Co., Inc. Recent Developments and Future Plans
Figure 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players in 2021
Figure 30. DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 31. Global Top 3 Players DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in 2021
Figure 32. Global Top 10 Players DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in 2021
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 34. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type in 2021
Figure 35. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share Forecast by Type (2023-2028)
Figure 36. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application in 2021
Figure 37. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share Forecast by Application (2023-2028)
Figure 38. North America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 39. North America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 40. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 41. United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 45. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 46. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 47. Germany DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 53. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2017-2028)
Figure 55. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 62. South America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 63. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 64. Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 67. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 68. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 69. Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. UAE DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. DNA Gyrase Subunit B (EC 5.99.1.3) Picture
Figure 2. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type in 2021
Figure 3. GYR-12
Figure 4. DS-2969
Figure 5. VXC-100
Figure 6. VT-12008911
Figure 7. Others
Figure 8. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application in 2021
Figure 9. Bacterial Infections Picture
Figure 10. Clostridium Diffclie Infections Picture
Figure 11. Klebsiella Pneumoniae Infections Picture
Figure 12. Others Picture
Figure 13. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2017-2028)
Figure 16. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region in 2021
Figure 17. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
Figure 23. DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
Figure 24. DNA Gyrase Subunit B (EC 5.99.1.3) Market Trends
Figure 25. Abgentis Limited Recent Developments and Future Plans
Figure 26. AstraZeneca Plc Recent Developments and Future Plans
Figure 27. Daiichi Sankyo Company Ltd Recent Developments and Future Plans
Figure 28. Merck & Co., Inc. Recent Developments and Future Plans
Figure 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players in 2021
Figure 30. DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 31. Global Top 3 Players DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in 2021
Figure 32. Global Top 10 Players DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in 2021
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 34. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type in 2021
Figure 35. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share Forecast by Type (2023-2028)
Figure 36. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application in 2021
Figure 37. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share Forecast by Application (2023-2028)
Figure 38. North America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 39. North America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 40. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 41. United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 45. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 46. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 47. Germany DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 53. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2017-2028)
Figure 55. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 62. South America DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 63. South America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 64. Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type (2017-2028)
Figure 67. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2017-2028)
Figure 68. Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Country (2017-2028)
Figure 69. Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. UAE DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
